ED50: <3 ng/ml, as determined by its ability to inhibit 5.0 ng/ml of BMP-4 induced alkaline phosphatase production by murine ATDC-5 cells. The expected ED50 for this effect, of Noggin, corresponding to a Specific Activity of 3.3x105U/mg.
Purity
>95% as determined by SDS-PAGE.
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from a solution containing 30% Acetonitrile and 0.1% TFA.
Storage
Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Synonyms
NOG
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Human Noggin Protein (A63302)? Please let us know so that we can list the citation on this page.
Alternative products to Recombinant Human Noggin Protein (A63302)
